Median Nerve Cross-Sectional Area and Body Weight in Carpal Tunnel Syndrome

Trial statusNot yet recruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18-75
SponsorKayseri City Hospital

About this trial

This study aims to evaluate the diagnostic accuracy of ultrasonographic measurements of the median nerve in patients with Carpal Tunnel Syndrome (CTS). While ultrasound is a common diagnostic tool, various physical factors can influence its results. The researchers will investigate how a patient's absolute body weight and Body Mass Index (BMI) affect the size of the median nerve cross-sectional area across different stages of disease severity. The goal is to determine if absolute body weight plays a 'masking' role that could lead to more precise diagnostic interpretations in clinical practice.

Eligibility criteria

Qualifiers

Patients aged between 18 and 75 years.

Clinical diagnosis of Carpal Tunnel Syndrome (CTS) based on symptoms (numbness, tingling, nocturnal pain in the median nerve distribution).

Electrophysiological confirmation of CTS according to the American

Association of Neuromuscular & Electrodiagnostic Medicine (AAEM) criteria.

Disqualifiers

Secondary causes of CTS (e.g., Diabetes Mellitus, Hypothyroidism, Rheumatoid -Arthritis, Chronic Renal Failure).

Coexisting neurological conditions (e.g., Cervical Radiculopathy,

Polyneuropathy, Brachial Plexopathy).

History of previous wrist surgery, trauma, or local corticosteroid injection within the last 6 months.

Trial design

Treatments tested in this trial

  • High-Resolution Ultrasonography and Electrophysiological Evaluation

Treatment groups

120 Participants
are divided into 1 treatment group

Locations

This trial has no locations

Sponsors and collaborators